2-((5-Chlorothiophen-2-yl)ethynyl)-9-methyl-N-phenethyl-9H-purin-6-amine

ID: ALA4527909

PubChem CID: 155545399

Max Phase: Preclinical

Molecular Formula: C20H16ClN5S

Molecular Weight: 393.90

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1cnc2c(NCCc3ccccc3)nc(C#Cc3ccc(Cl)s3)nc21

Standard InChI:  InChI=1S/C20H16ClN5S/c1-26-13-23-18-19(22-12-11-14-5-3-2-4-6-14)24-17(25-20(18)26)10-8-15-7-9-16(21)27-15/h2-7,9,13H,11-12H2,1H3,(H,22,24,25)

Standard InChI Key:  BSQOPKHFOQKBEZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    4.5149   -5.5125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2246   -5.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2217   -4.2804    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5131   -3.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8069   -5.1036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8036   -4.2871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0260   -4.0378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5487   -4.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0313   -5.3589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5105   -3.0580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2169   -2.6471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9313   -5.5087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6397   -5.9162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3480   -6.3237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4354   -7.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2350   -7.3031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6425   -6.5947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0947   -5.9884    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.4596   -6.5912    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.9259   -3.0534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6323   -2.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3400   -3.0511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0459   -2.6409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0437   -1.8228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3297   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6267   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7820   -6.1372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 12 13  3  0
  2 12  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  1  0
 17 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  9 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4527909

    ---

Associated Targets(Human)

TSPO Tchem Translocator protein (484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.90Molecular Weight (Monoisotopic): 393.0815AlogP: 4.13#Rotatable Bonds: 4
Polar Surface Area: 55.63Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.11CX LogP: 5.34CX LogD: 5.34
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -0.82

References

1. Yu J, Mannes P, Jung YH, Ciancetta A, Bitant A, Lieberman DI, Khaznadar S, Auchampach JA, Gao ZG, Jacobson KA..  (2018)  Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.,  (11): [PMID:30568760] [10.1039/C8MD00317C]
2. Abel B, Murakami M, Tosh DK, Yu J, Lusvarghi S, Campbell RG, Gao ZG, Jacobson KA, Ambudkar SV..  (2022)  Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2.,  231  [PMID:35152062] [10.1016/j.ejmech.2022.114103]

Source